Literature DB >> 30140912

Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial.

John A Zic1, Brittany T Straka2,3, Laura Y McGirt4,5, Hui Nian6, Chang Yu6, Nancy J Brown2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30140912      PMCID： PMC6233739          DOI： 10.1001/jamadermatol.2018.2510

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.

Authors:  N Booken; M Heck; J P Nicolay; C D Klemke; S Goerdt; J Utikal
Journal:  Br J Dermatol       Date:  2011-01-28       Impact factor: 9.302

2.  Aprepitant in the treatment of refractory pruritus secondary to cutaneous T-cell lymphoma.

Authors:  H A Borja-Consigliere; A López-Pestaña; M J Vidal-Manceñido; A Tuneu-Valls
Journal:  Actas Dermosifiliogr       Date:  2013-10-16

3.  Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.

Authors:  Barry Ladizinski; Andrea Bazakas; Elise A Olsen
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

Review 4.  Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.

Authors:  Sumana Devata; Ryan A Wilcox
Journal:  Am J Clin Dermatol       Date:  2016-06       Impact factor: 7.403

5.  Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.

Authors:  David Jiménez Gallo; Cristina Albarrán Planelles; Mario Linares Barrios; María José Fernández Anguita; Juan Márquez Enríquez; María Eugenia Rodríguez Mateos
Journal:  Dermatol Ther       Date:  2013-12-02       Impact factor: 2.851

6.  Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

Authors:  Johanna S Song; Marianne Tawa; Nicole G Chau; Thomas S Kupper; Nicole R LeBoeuf
Journal:  BMC Cancer       Date:  2017-03-16       Impact factor: 4.430
  6 in total
  3 in total

Review 1.  The Itch-Scratch Cycle: A Neuroimmune Perspective.

Authors:  Madison R Mack; Brian S Kim
Journal:  Trends Immunol       Date:  2018-11-21       Impact factor: 16.687

2.  Neurokinin 1 Receptor Antagonists for Pruritus.

Authors:  Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal:  Drugs       Date:  2021-03-06       Impact factor: 9.546

Review 3.  NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.

Authors:  Marcelina Pojawa-Gołąb; Kamila Jaworecka; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2019-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.